GT Biopharma, Inc. - Common Stock, par value $0.001 (GTBP)

Historical Holders from Q4 2023 to Q1 2025

Symbol
GTBP on Nasdaq
CUSIP
36254L308
Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
2.24M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.24M
Holdings value
$29.3M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
18
Number of buys
6
Number of sells
-3
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GT Biopharma, Inc. - Common Stock, par value $0.001 (GTBP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CYTOVANCE BIOLOGICS INC 9.8% $512K 219K CYTOVANCE BIOLOGICS INC Sep 30, 2024

Institutional Holders of GT Biopharma, Inc. - Common Stock, par value $0.001 (GTBP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 6 $14.00 $2.33 1
2024 Q4 1.24M $29.3M -$3.84K $3.05 18
2024 Q3 1.25M $35.3M +$5.34M $2.31 15
2024 Q2 1.08M $38.1M +$37.9M $2.83 16
2024 Q1 277 $1.23K +$10.00 $4.40 3
2023 Q4 208 $53.00 +$53.00 $0.26 2